Zietman AL - Search Results

1

Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09.

Zietman AL, Bae K, Slater JD, Shipley WU, Efstathiou JA, Coen JJ, Bush DA, Lunt M, Spiegel DY, Skowronski R, Jabola BR, Rossi CJ. Zietman AL, et al. J Clin Oncol. 2010 Mar 1;28(7):1106-11. doi: 10.1200/JCO.2009.25.8475. Epub 2010 Feb 1. J Clin Oncol. 2010. PMID: 20124169 Free PMC article. Clinical Trial.

2

Radiation therapy in the management of early stage Hodgkin's disease presenting in later life.

Zietman AL, Linggood RM, Brookes AR, Convery K, Piro A. Zietman AL, et al. Cancer. 1991 Nov 1;68(9):1869-73. doi: 10.1002/1097-0142(19911101)68:9<1869::aid-cncr2820680903>3.0.co;2-h. Cancer. 1991. PMID: 1913538

3

Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome.

Zietman AL, Coen JJ, Shipley WU, Willett CG, Efird JT. Zietman AL, et al. J Urol. 1994 Mar;151(3):640-5. doi: 10.1016/s0022-5347(17)35036-x. J Urol. 1994. PMID: 7508522

4

The effect of pelvic radiation therapy on serum levels of prostate specific antigen.

Willett CG, Zietman AL, Shipley WU, Coen JJ. Willett CG, et al. Among authors: zietman al. J Urol. 1994 Jun;151(6):1579-81. doi: 10.1016/s0022-5347(17)35306-5. J Urol. 1994. PMID: 7514692

5

Radical prostatectomy for adenocarcinoma of the prostate: the influence of preoperative and pathologic findings on biochemical disease-free outcome.

Zietman AL, Edelstein RA, Coen JJ, Babayan RK, Krane RJ. Zietman AL, et al. Urology. 1994 Jun;43(6):828-33. doi: 10.1016/0090-4295(94)90144-9. Urology. 1994. PMID: 7515206

6

Re: The value of serial prostate specific antigen determinations 5 years after radiotherapy: steeply increasing values characterize 80% of patients.

Zietman AL, Shipley WU. Zietman AL, et al. J Urol. 1994 Nov;152(5 Pt 1):1564-5; author reply 1565-6. J Urol. 1994. PMID: 7523713 No abstract available.

7

Radical prostatectomy and radical radiation therapy for clinical stages T1 to 2 adenocarcinoma of the prostate: new insights into outcome from repeat biopsy and prostate specific antigen followup.

Zietman AL, Shipley WU, Coen JJ. Zietman AL, et al. J Urol. 1994 Nov;152(5 Pt 2):1806-12. doi: 10.1016/s0022-5347(17)32389-3. J Urol. 1994. PMID: 7523726 Review.

8

Residual disease after radical surgery or radiation therapy for prostate cancer. Clinical significance and therapeutic implications.

Zietman AL, Shipley WU, Willett CG. Zietman AL, et al. Cancer. 1993 Feb 1;71(3 Suppl):959-69. doi: 10.1002/1097-0142(19930201)71:3+<959::aid-cncr2820711411>3.0.co;2-l. Cancer. 1993. PMID: 7679046 Review.

9

Adjuvant irradiation after radical prostatectomy for adenocarcinoma of prostate: analysis of freedom from PSA failure.

Zietman AL, Coen JJ, Shipley WU, Althausen AF. Zietman AL, et al. Urology. 1993 Sep;42(3):292-8; discussion 298-9. doi: 10.1016/0090-4295(93)90618-k. Urology. 1993. PMID: 7691014

10

Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone.

Shipley WU, Verhey LJ, Munzenrider JE, Suit HD, Urie MM, McManus PL, Young RH, Shipley JW, Zietman AL, Biggs PJ, et al. Shipley WU, et al. Among authors: zietman al. Int J Radiat Oncol Biol Phys. 1995 Apr 30;32(1):3-12. doi: 10.1016/0360-3016(95)00063-5. Int J Radiat Oncol Biol Phys. 1995. PMID: 7721636 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

366 results

Search Page

Filters